Clinical laboratories want to plan for ways to improve their workflow, reduce turnaround time, and efficiently use labor and financial resources, while balancing the need to improve quality.
Designing, upgrading, and choosing the right instruments for a clinical lab are complicated tasks. Even for experienced laboratory directors and managers, it isn’t always apparent how such processes should be conducted, or how a lab should go about ensuring that its specific needs are addressed.
For an increasing number of laboratory directors and managers, coping with shifts in the healthcare marketplace is an everyday reality. But those who are prepared may see the challenges of such change as opportunities as well.
CLP spoke with Roger D. Klein, MD, JD, FCAP, medical director for molecular oncology at the Cleveland Clinic, and chair of the Association for Molecular Pathology ’s professional relations committee, to find out more about AMP’s revised policy on direct-to-consumer genetic testing,
Self contained and easily moveable, the MicroFlow I workstation comes with an integral recessed work surface to contain spills.
After three recent outbreaks of carbapenem-resistant Enterobacteriaceae cast a light on the dangers associated with multi-drug-resistant infections, Nanosphere recently reaffirmed the clinical benefits of its Verigene gram-negative blood culture test.
PositiveID Corp has completed a first round of testing for its handheld, real-time polymerase chain reaction-based pathogen detection system, which reportedly delivers positive results within 20 minutes.
The pneumatic tube system carrier’s design enables users to use one hand to hold the unit while using the other hand to load contents and latch it shut.
The OxA oxalic acid reagent kit is designed to digest, neutralize, and resuspend clinical specimens properly for the improved recovery of Mycobacterium spp from specimens containing Pseudomonas spp.
IES is launching a crowdfunding campaign to develop the first clinical diagnostic test for systemic lupus erythematosus, based on the unique interferon signature of the disease.
Under a new agreement, Biodesix and Inivata will investigate the clinical utility of blood-based next-generation sequencing tests for patients with non-small cell lung cancer.
The new partnership will focus on creating a universal test system for clinical trials of targeted cancer therapies, with the goal of developing a more comprehensive tool for precision medicine.
Data from the ongoing NBRST trial suggest that Agendia’s BluePrint 80-gene molecular subtyping assay more accurately identifies molecular subgroups and may be a better guide for neoadjuvant chemotherapy than IHC/FISH assays.
A new collaboration focused on digital pathology enhances cutting-edge capabilities to improve workflow and reliable, consistent processes.
In a study of breast biopsy interpretations, concordance between individual pathologists and an expert consensus panel was just 75%, suggesting a need for a formal second opinion in many cases.
Developed for small and medium-sized laboratories, the PelvoCheck CT/NG diagnostic kit from Greiner Bio-One is especially useful for reliably testing asymptomatic patients for Chlamydia trachomatis and Neisseria gonorrhoeae bacteria.
Flow Sciences Inc, Leland, NC, has released a new series of process enclosures, designed and customized to protect process equipment and personnel.
Two studies confirm that the great versatility of viruses can result in deaths, and requires continued receptor-binding and structural studies.
A line of lyophilized controls is designed to simulate human serum samples for determining linearity, calibration verification, and verification of reportable range on Roche analyzers.
The collaboration leverages grants from the Bill & Melinda Gates Foundation and Paul G. Allen Family Foundation to automate rapid ebola testing and increase access to reliable data from the field.